Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
元の記事を読む ↗最新の金融ニュース見出しと発行元の短い概要。全文は元のサイトでお読みください。
全 2 件中 1 ~ 2 を表示
Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
元の記事を読む ↗The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
元の記事を読む ↗見出しと短い概要の権利は各発行元に帰属します。全文は元のサイトで開き、購読が必要な場合があります。情報および教育目的です。